Pre-Open Stock Movers 07/07: (DARE) (OPNT) (BHVN) Higher; (BSQR) (IDYA) (LOAN) Lower (more...)

Pre-Open Stock Movers:

Dare Bioscience (NASDAQ: DARE) 58.9% HIGHER; entered into an agreement with the Bill & Melinda Gates Foundation, under which we were awarded a new grant of up to $48.95 million (the “Grant”) to support the development of DARE-LARC1, our investigational user-controlled, long-acting reversible contraceptive.

Opiant Pharmaceuticals, Inc.(NASDAQ: OPNT) 34.5% HIGHER; Announced positive top-line results from its confirmatory pharmacokinetic study for OPNT003, nasal nalmefene, for opioid overdose.

Bsquare (NASDAQ: BSQR) 23.3% LOWER; Enters Side Letter for $50M at Market Issuance Sales Agreement, Offers Guidance

OncoSec Medical Incorporated (NASDAQ: ONCS) 20.8% HIGHER; announced it has entered into a Clinical Trial Collaboration and Supply Agreement with Merck (known as MSD outside the United States and Canada) to evaluate the combination of OncoSec's DNA-plasmid interleukin-12 (IL-12) TAVO (tavokinogene telseplasmid) with Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in a global Phase 3 randomized clinical trial, KEYNOTE-C87. The planned clinical trial will evaluate the overall survival of patients treated with the TAVO in combination with KEYTRUDA® versus standard of care in late-stage patients with metastatic melanoma who are refractory to immune checkpoint therapy.

Jaguar Animal Health (NASDAQ: JAGX) 12.8% HIGHER; Cantor Fitzgerald initiates coverage with an Overweight rating and a price target of $5.00.

Biohaven Pharmaceutical (NYSE: BHVN) 12% HIGHER; announced preliminary net product revenue of NURTEC ODT (rimegepant) for the second quarter of 2021. Based on preliminary unaudited financial information, the Company reported $93 million in net product revenue from sales of NURTEC ODT in the second quarter of 2021. Total prescriptions of NURTEC ODT from product launch to date (as of June 30, 2021) were over 750,000, with approximately 38,000 unique prescribers.

IDEAYA Biosciences, Inc. (Nasdaq: IDYA) 10.9% LOWER; announced that it intends to offer and sell up to $80 million of shares of its common stock in an underwritten public offering.

Immersion Corporation (NASDAQ: IMMR) 9% HIGHER; sees second-quarter revenues between $10.5 to $11.0 million, versus the consensus of $8 million.

Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) 6.7% LOWER; announced today that it is proposing to offer its common shares, par value $0.001 per share, in an underwritten public offering.

Ceragon Networks (NASDAQ: CRNT) 5% HIGHER; has been awarded a multi-year managed services agreement by a leading network service provider in the US. The service provider focuses on delivering a comprehensive suite of connectivity services to enterprise customers leveraging its fiber optic network. As part of its growth plans, it recently expanded its offering to include wireless connectivity, broadening its portfolio of broadband access and cloud solutions. The service provider will utilize Ceragon's managed services to improve the performance of its newly acquired wireless network, ensuring a smooth transition and optimal management, with a preventive maintenance approach for predictable OPEX.

ConforMIS Inc (NASDAQ: CFMS) 4.8% HIGHER; reached a settlement with Wright Medical and Tornier related to patent infringement lawsuit.

Sunnova (NYSE: NOVA) 4.2% HIGHER; Raymond James upgraded from Outperform to Strong Buy with a price target of $50.00.

SMART Global Holdings, Inc. (NASDAQ: SGH) 4% HIGHER; reported Q3 EPS of $1.39, $0.30 better than the analyst estimate of $1.09. Revenue for the quarter came in at $437.7 million versus the consensus estimate of $415.57 million. SMART Global Holdings, Inc. sees Q4 2021 EPS of $1.45-$1.75, versus the consensus of $1.23. SMART Global Holdings, Inc. sees Q4 2021 revenue of $440-480 million, versus the consensus of $439.35 million.

ChemoCentryx (NASDAQ: CCXI) 3.9% HIGHER; Stifel upgraded from Hold to Buy with a price target of $31.00 (from $26.00).

Shenandoah Telecommunications (NASDAQ: SHEN) 3.3% LOWER; Raymond James downgraded from Market Perform to Underperform.

Ellington Financial Inc. (NYSE: EFC) 2.9% LOWER; announced today that it has commenced an underwritten public offering of 7,500,000 shares of common stock.

Coinbase Global Inc. (NASDAQ: COIN) 2.2% HIGHER; Oppenheimer raised the price target to $444.00 (from $334.00) while maintaining an Outperform rating.

Steel Dynamics, Inc. (NASDAQ: STLD) 2.2% HIGHER; announced that the company's board of directors authorized an additional share repurchase program of up to $1.0 billion of the company's common stock. The authorization is effective immediately and is additive to the previous $500 million program, which had $51 million remaining authorized and available for repurchase at June 30, 2021.

You May Also Be Interested In

• Baird Defends Cardinal Health (CAH): 'Market fears played out, buyers on weakness'
• Snap (SNAP), Meta (META) gain as House orders sale or ban of TikTok
• IT services stocks fall following Infosys' numbers